Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Revance Therapeutics Inc (NASDAQ:RVNC)

23.45
Delayed Data
As of Aug 17
 -0.30 / -1.26%
Today’s Change
12.35
Today|||52-Week Range
28.30
+13.29%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close23.75
Today’s open23.65
Day’s range23.35 - 24.10
Volume141,261
Average volume (3 months)187,128
Market cap$722.7M
Dividend yield--
Data as of 08/17/2017

Growth & Valuation

Earnings growth (last year)-5.30%
Earnings growth (this year)-16.79%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,939.92
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.25-1.53%
PTCTPTC Therapeutics Inc-0.13-0.73%
ZIOPZIOPHARM Oncology In...-0.19-3.56%
HSKAHeska Corp-0.01-0.01%
Data as of 08/17/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$300.0K
Annual profit (last year)-$89.3M
Net profit margin-29,756.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
Chief Operating Officer
Abhay Joshi
Corporate headquarters
Newark, California

Forecasts